Cutting Edge Systemic Treatments: Oral and Biologic | Alexander Egeberg, MD, PhD, DMSc | Denmark

Cutting Edge Systemic Treatments: Oral and Biologic | Alexander Egeberg, MD, PhD, DMSc | Denmark

Inflammatory Bowel Disease – Clinical Features, Identifying Those at Risk | Alexander Egeberg, PhDПодробнее

Inflammatory Bowel Disease – Clinical Features, Identifying Those at Risk | Alexander Egeberg, PhD

Microcystic adnexal carcinoma (MAC) (AIP France 2021 - Case 3)Подробнее

Microcystic adnexal carcinoma (MAC) (AIP France 2021 - Case 3)

ESHG 2019 - Dr. Alexander HoischenПодробнее

ESHG 2019 - Dr. Alexander Hoischen

E113: Editor's Picks May 2024Подробнее

E113: Editor's Picks May 2024

Lecture-210: Dermatoses of Male Genitalia. Part-2. Chapter 109. Rooks 10th eds.Подробнее

Lecture-210: Dermatoses of Male Genitalia. Part-2. Chapter 109. Rooks 10th eds.

Safety, efficacy and drug survival of biologics and biosimilars, A. Egeberg et alПодробнее

Safety, efficacy and drug survival of biologics and biosimilars, A. Egeberg et al

Alexander Lazar, MD, PhD - Frontiers In Academic Pathology 2015Подробнее

Alexander Lazar, MD, PhD - Frontiers In Academic Pathology 2015

Grand Opening of Cutting Edge Medical University Campus in West Des MoinesПодробнее

Grand Opening of Cutting Edge Medical University Campus in West Des Moines

Why we need to stratify in treatment of psoriasis | Lars Iversen, MD | DenmarkПодробнее

Why we need to stratify in treatment of psoriasis | Lars Iversen, MD | Denmark

Alexander Stratigos, MD, PhD, on the latest data investigating the use of cemiplimab in BCCПодробнее

Alexander Stratigos, MD, PhD, on the latest data investigating the use of cemiplimab in BCC

Sprifermin Case Study | Marc HochbergПодробнее

Sprifermin Case Study | Marc Hochberg